288 related articles for article (PubMed ID: 25686799)
1. The Challenges and Opportunities Associated with Reimbursement for Obesity Pharmacotherapy in the USA.
Baum C; Andino K; Wittbrodt E; Stewart S; Szymanski K; Turpin R
Pharmacoeconomics; 2015 Jul; 33(7):643-53. PubMed ID: 25686799
[TBL] [Abstract][Full Text] [Related]
2. Drug reimbursement and GPs' prescribing decisions: a randomized case-vignette study about the pharmacotherapy of obesity associated with type 2 diabetes: how GPs react to drug reimbursement.
Verger P; Rolland S; Paraponaris A; Bouvenot J; Ventelou B
Fundam Clin Pharmacol; 2010 Aug; 24(4):509-16. PubMed ID: 19840120
[TBL] [Abstract][Full Text] [Related]
3. Willingness to pay for obesity pharmacotherapy.
Doyle S; Lloyd A; Birt J; Curtis B; Ali S; Godbey K; Sierra-Johnson J; Halford JC
Obesity (Silver Spring); 2012 Oct; 20(10):2019-26. PubMed ID: 22301901
[TBL] [Abstract][Full Text] [Related]
4. US health policy and prescription drug coverage of FDA-approved medications for the treatment of obesity.
Gomez G; Stanford FC
Int J Obes (Lond); 2018 Mar; 42(3):495-500. PubMed ID: 29151591
[TBL] [Abstract][Full Text] [Related]
5. Paying for obesity: a changing landscape.
Simpson LA; Cooper J
Pediatrics; 2009 Jun; 123 Suppl 5():S301-7. PubMed ID: 19470607
[TBL] [Abstract][Full Text] [Related]
6. Pharmacotherapy for the management of obesity.
Patel D
Metabolism; 2015 Nov; 64(11):1376-85. PubMed ID: 26342499
[TBL] [Abstract][Full Text] [Related]
7. Barriers and Solutions for Prescribing Obesity Pharmacotherapy.
Fujioka K; Harris SR
Endocrinol Metab Clin North Am; 2020 Jun; 49(2):303-314. PubMed ID: 32418592
[TBL] [Abstract][Full Text] [Related]
8. Current Options for the Pharmacotherapy of Obesity.
Gouni-Berthold I; Berthold HK
Curr Pharm Des; 2019; 25(18):2019-2032. PubMed ID: 31298150
[TBL] [Abstract][Full Text] [Related]
9. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
10. Report on financing the new model of family medicine.
Spann SJ;
Ann Fam Med; 2004 Dec; 2 Suppl 3(Suppl 3):S1-21. PubMed ID: 15654084
[TBL] [Abstract][Full Text] [Related]
11. Financial implications of a model heart failure disease management program for providers, hospital, healthcare systems, and payer perspectives.
Whellan DJ; Reed SD; Liao L; Gould SD; O'connor CM; Schulman KA
Am J Cardiol; 2007 Jan; 99(2):256-60. PubMed ID: 17223429
[TBL] [Abstract][Full Text] [Related]
12. Practical perspectives on the management of overweight and obesity.
Gregory RS; Handelsman Y; Pezalla EJ; Pikelny D
Am J Manag Care; 2014 Mar; 20(3 Suppl):S64-75. PubMed ID: 24773374
[TBL] [Abstract][Full Text] [Related]
13. Obesity pharmacotherapy from a regulatory perspective: overview and key challenges.
Hutchinson NI; Ryder SW
Clin Pharmacol Ther; 2007 May; 81(5):756-60. PubMed ID: 17392723
[TBL] [Abstract][Full Text] [Related]
14. Quality and safety in medical care: what does the future hold?
Liang BA; Mackey T
Arch Pathol Lab Med; 2011 Nov; 135(11):1425-31. PubMed ID: 22032568
[TBL] [Abstract][Full Text] [Related]
15. Health economics of weight management: evidence and cost.
Kouris-Blazos A; Wahlqvist ML
Asia Pac J Clin Nutr; 2007; 16 Suppl 1():329-38. PubMed ID: 17392129
[TBL] [Abstract][Full Text] [Related]
16. Future and implications of reimbursement for obesity treatment.
Stern JS; Kazaks A; Downey M
J Am Diet Assoc; 2005 May; 105(5 Suppl 1):S104-9. PubMed ID: 15867905
[TBL] [Abstract][Full Text] [Related]
17. Is Obesity the New Hypertension? Parallels in the Evolution of Obesity and Hypertension as Recognized Disease States.
Umashanker D; Shukla AP; Saunders KH; Aronne LJ
Curr Atheroscler Rep; 2017 Aug; 19(8):35. PubMed ID: 28660593
[TBL] [Abstract][Full Text] [Related]
18. Obesity pharmacotherapy - update 2023.
Haluzík M; Müllerová D; Sucharda P; Boženský J; Holéczy P; Fried M; Hainer V; Kunešová M; Málková I; Slabá Š; Šrámková P; Braunerová RT
Cas Lek Cesk; 2023; 162(1):19-31. PubMed ID: 37185039
[TBL] [Abstract][Full Text] [Related]
19. Saga of payment systems of ambulatory surgery centers for interventional techniques: an update.
Manchikanti L; Singh V; Hirsch JA
Pain Physician; 2012; 15(2):109-30. PubMed ID: 22430649
[TBL] [Abstract][Full Text] [Related]
20. Pharmacotherapy for the treatment of obesity.
Sweeting AN; Hocking SL; Markovic TP
Mol Cell Endocrinol; 2015 Dec; 418 Pt 2():173-83. PubMed ID: 26360586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
